Article

Profiling crystal engineered ligands for targeting treatment resistant androgen receptors

2026-05-05

Abstract excerpt

Prostate cancer (PCa) is one of the principal contributors to health burden in the aging male population. PCa develops through dysregulation of androgen receptor (AR) signaling pathways. Despite improvements in diagnostic techniques and interventions, no pharmacological measures with long term efficacy have been established once PCa advances to castration resistant prostate cancer (CRPC). To circumvent this issue,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1a54af42-cea0-54a3-9158-cf3e2055b475
DOI: 10.64898/2026.05.01.721995

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Profiling crystal engineered ligands for targeting treatment resistant androgen receptorsDOI 10.64898/2026.05.01.721995Read

Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer.Semantic proximity Read

Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancerSemantic proximity Read

Androgen receptor antagonists: a patent review (2008-2011).Semantic proximity Read

In Silico Discovery of Androgen Receptor Antagonists with Activity in Castration Resistant Prostate CancerSemantic proximity Read

Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancerSemantic proximity Read

Targeting the BAG-1 family of co-chaperones in lethal prostate cancerSemantic proximity Read

Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate CancerSemantic proximity Read

Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift AssaySemantic proximity Read

Scaffolds, Sponges, and Steroids: Unraveling the RNA–Kinase Cross-Talk in Advanced Prostate CancerSemantic proximity Read

Synthesis and in vitro characterization of ionone-based chalcones as novel antiandrogens effective against multiple clinically relevant androgen receptor mutants.Semantic proximity Read

N-terminal domain of androgen receptor is a major therapeutic barrier and potential pharmacological target for treating castration resistant prostate cancer: a comprehensive reviewSemantic proximity Read

Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.Semantic proximity Read